Pandemic related inaccessibility prevented me from getting timely Cardiology appointments this year. As a result, I ended up with my scheduled consultation and a second opinion consultation spaced just two weeks apart. I talked with a 2nd electrophysiologist today. He had records about me dating back to 2009. I had consulted with a cardiologist who was an exercise physiologist and another electrophysiologist at that clinic. After reviewing the recent history of paroxysmal atrial fibrillation again we had a very interesting conversation.
He reviewed the issues of rate versus rhythm control again.
The priority is reducing stroke risk and that is done by anticoagulation. When
it comes down to trying to maintain a normal sinus rhythm and all the measures
that involves the decision is based on "How much does the arrhythmia
bother you". He gave many examples that I was familiar with including
the person who is not aware of being in atrial fibrillation until you tell
them. I have made the diagnosis many times by taking vital signs on people and
noticing their irregularly irregular pulse and pulse deficit. Most of the time
they have no awareness of the arrhythmia. In some cases, they have been advised
of the arrhythmia but decided not to do anything about it. I am in the category
of people with what I like to call "cardiac awareness". I know
immediately if I am in atrial fibrillation or even having palpitations. I check
my own vital signs 3 times a day-in triplicate. We had a discussion of my
neurotic tendencies and how much this rhythm problem bothers me – even if I am
in atrial fibrillation only a few times a year for a brief period.
This point is also critical when it comes to treating
psychiatric conditions. A misrepresentation of medical and psychiatric treatment
is that physicians are drumming up business and manipulating populations into
unnecessary care. Either that - or the care is just automatic and dependent on
a diagnosis or blood test. One of the
favorite fabrications is that the DSM is designed expand treatment and line the
pockets of both psychiatrists and pharmaceutical companies. In fact, I have not
seen a patient in outpatient practice that was not there because they were
distressed, bothered by their current symptoms, and unable to get help anywhere
else. In my conversation today with the electrophysiologist we are
contemplating a 3-hour procedure under general anesthesia with significant
potential complications including bleeding, stroke, the need for pacemaker
placement, and death - all based on my subjective assessment of how much
this arrhythmia bothers me. Based on level of risk – there are no equivalent
decisions in psychiatry.
To reinforce that point, he said that cardiologists have
been trying to show that rhythm control is superior to rate control for about
40 years and the evidence was very thin and possible non-existent. Based on the
discussion of stroke prevention, that assumes that anticoagulation reduces
stroke risk on the atrial fibrillation group to the same level as the normal
sinus rhythm or rhythm group. I would give the edge to the rhythm control group
on that parameter. In terms of lifestyle
measures rhythm control would potentially eliminate other nuisance rhythms like
bigeminy and trigeminy if the origin was in the pulmonary veins. Additional mapping occurs during the
procedure to see if there is another focus for these rhythms. The atrial flutter would need to be
eliminated in a procedure on the right side of the heart. A concern that we did
not discuss is a sudden worsening of the atrial fibrillation or atrial flutter
to the point that a different antiarrhythmic would need to be used. I have seen amiodarone added at that point
and there are many complications with that medication – including death from
pulmonary complications.
We got into a discussion about phenotypes based on the
recent New England Journal of Medicine review. The focal point was
whether a paroxysmal atrial fibrillation pattern like mine was easier to
covert by an ablation procedure and remain in a normal sinus rhythm and remain
in that rhythm. He was aware of the
review, but thought that not enough is currently known about phenotypes. That seem to be a problem with a lot or
intermediate or endophenotypes that are used in psychiatry and other fields
like asthma or multiple sclerosis. On
the surface there appear to be a lot of easily described apparent subgroups,
but the natural history of those groups and the underlying pathophysiology is
essentially unknown and considerable heterogeneity in severity, course, and
outcomes remains.
There was a brief discussion of the athlete’s heart. He had no reason to doubt that the slightly
enlarged left atrium and aortic root on my echocardiogram was due to decades of
intense athletic activity and knew that was also one of many potential factors
leading to atrial fibrillation.
The question of early rather than late ablation was
discussed and the idea that there is progressive remodeling in the heart due to
atrial fibrillation even in the case of a few episodes per year. He thought
that in general, ablation prior to persistent atrial fibrillation resulted in
better outcomes and earlier ablation was better than late ablation. He emphasized that these were across group
comparisons and there was a heterogeneity factor at work. All the ablation that he does is
radiofrequency ablation and the result is anywhere from 75-90% effective
depending on how well the pulmonary vein isolation goes. That is balances against a 2-3% risk of
adverse effects – largely in the form of bleeding and hematoma formation at the
catheter sites. Chest pain and migraine
headaches are also common post procedure.
Very serious complications during the procedure including death and the
need for pacemaker placement were at about 1%.
The only death he had seen during the procedure was unrelated to the
ablation.
He had a different opinion about the dose of flecainide and
moving on to other antiarrhythmics like sotalol. He thought I could take twice as much
flecainide as a standard trial dose 150 mg BID), but agreed that it might not
make much difference in the low frequency of atrial fibrillation. That is quite a difference in flecainide
dosing compared to the other group of cardiologists that I consult with.
In terms of recovery time give my current workout schedule
he thought it would take a month to get back up to speed. At that point I could resume my usual
activities. If I decided to do that soon it would mean putting speedskating on
hold for another winter.
That is where I am at after the second opinion. Assuming that my insurance is the same across
facilities – I have two to choose from and two electrophysiologists willing to
try the ablation. My choice is to weigh a moderately successful procedure
against the low frequency but significant complications and make the decision.
And I know at this point it is an elective procedure based on how disruptive
this arrhythmia is to my life. It is possible that at some point due to worsening
atrial fibrillation and/or flutter and associated worsening symptoms or cardiac
function that it would be less elective.
In terms of comparison with psychiatric practice and the
usual critiques – these are the same choices that people would have if they
were seeing me in clinic with a few exceptions. I am not treating anyone with
invasive procedures or general anesthesia.
The medications prescribed by psychiatrists are generally safer that
antiarrhythmics. There is a long list of absurd complaints made by
antipsychiatrists that could similarly be applied to this cardiology scenario.
But most importantly – in either case the treatment decision by the patient is
subjectively based on how much the symptom is bothering them. I do not know how
to translate 4 hours of symptoms per year into what I have been told about
daily anxiety and depression symptoms every week. Some of those symptoms are
also cardiac in origin.
But I think this highlights a completely neglected
dimension of medical and psychiatric practice. Treatment is based on more than a rational
informed consent discussion and weighing the risks and benefits. It is based on
more than a scientific diagnosis and confirmatory tests.
It is highly subjective and based on the personal
experience of the patient that is rarely know to casual observers.
George Dawson, MD, DFAPA
I thought I would add some additional observations about my recent cardiology consults and how they compare with psychiatric practice. Putting these in the main body of the post would have increased the reading difficulty.
Categorial diagnosis versus something else: It is fashionable these days to say that
medically diagnosed syndromes are a thing of the past and we should be making
dimensional diagnoses or systems diagnoses.
Of course, these have been tried in the past. Contrary to a standardized
approach – the diagnostic and treatment approach is highly practice dependent
as can be noted by comparing the recommendations of the last 2 posts. In addition, there is a fine structure to
categories that is so detailed that it cannot be listed as criteria. Diagnostic
categories in medicine have been talked about as prototypes – but it is really
an indexing system for each physician to catalogue everything they know about
that disease especially in the populations they are treating.
There may be objections to this conceptualization of
categorial diagnosis. Shouldn’t all
clinicians be making the same diagnosis based on some sort of
standardization? That is certainly the
argument many people make – but it certainly is not realistic. Experts have seen more cases, know more
variations, and have seen more diagnostic errors in the conditions they are diagnosing
and treating. They have studied those conditions more thoroughly than anyone
else. To suggest that a non-expert can read criteria in a diagnostic manual or
administer a checklist of symptoms from that manual and get the same results is
a significant misunderstanding of the process.
Any medical category can be parsed based on severity and
using that metric will lead to different assessments and treatments within the
same category That is as true for cardiac arrhythmias as well as categories of
depression and psychosis. A related issue on the medical side is that all the
associated symptoms that might be lumped into lifestyle effects or suggest a
psychiatric disorder are basically ignored if they do not show up on a PHQ-3
that is given as part of a preregistration packet.
The good news here is that subjectivity is alive and well
in medicine and psychiatry as it should be.
Our biology determines unique presentations of our illnesses as well as
our reaction to them. The physicians
treating us have to understand that.